Cargando…
Synergy of ruthenium metallo-intercalator, [Ru(dppz)(2)(PIP)](2+), with PARP inhibitor Olaparib in non-small cell lung cancer cells
Poly(ADP-ribose) polymerase (PARP) are critical DNA repair enzymes that are activated as part of the DNA damage response (DDR). Although inhibitors of PARP (PARPi) have emerged as small molecule drugs and have shown promising therapeutic effects, PARPi used as single agents are clinically limited to...
Autores principales: | Yusoh, Nur Aininie, Chia, Suet Lin, Saad, Norazalina, Ahmad, Haslina, Gill, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879939/ https://www.ncbi.nlm.nih.gov/pubmed/36702871 http://dx.doi.org/10.1038/s41598-023-28454-x |
Ejemplares similares
-
Discovery of
Ruthenium(II) Metallocompound and Olaparib
Synergy for Cancer Combination Therapy
por: Yusoh, Nur Aininie, et al.
Publicado: (2023) -
Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy
por: Yusoh, Nur Aininie, et al.
Publicado: (2020) -
Recent Developments in the Interactions of Classic Intercalated Ruthenium Compounds: [Ru(bpy)(2)dppz](2+) and [Ru(phen)(2)dppz](2+) with a DNA Molecule
por: Jia, Fuchao, et al.
Publicado: (2019) -
Ruthenium(II)
Polypyridyl Complexes as FRET Donors:
Structure- and Sequence-Selective DNA-Binding and Anticancer Properties
por: Elgar, Christopher E., et al.
Publicado: (2023) -
Ultrafast in cellulo photoinduced dynamics processes of the paradigm molecular light switch [Ru(bpy)(2)dppz](2+)
por: De la Cadena, Alejandro, et al.
Publicado: (2016)